University of Texas at Arlington research projects contributed $59 million to the national economy in 2024—an increase of 39% from 2023, according to a new report from the Institute for Research on Innovation and Science (IRIS). UTA has invested heavily in research infrastructure, purchasing cutting-edge scientific equipment and technology, such as North Texas’ most advanced gene sequencer and a super-sensitive magnetic resonance imaging machine for the Clinical Imaging Research Center. The funds also support collaboration with other research organizations. 

A new study in the peer-reviewed Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I (RIG-I) agonist RNA (RAR) induces innate immune signaling and death of hepatocellular carcinoma cells in vitro.

An interdisciplinary study led by Kyushu University combining political science and psychology shows that individuals who view the world through a "friend or foe" mindset are more likely to perceive outsiders as a threat. They tend to believe more in conspiracy theories, and hold more negative attitudes toward international relations. Researchers hope to contribute insights that lead to more effective conflict management and lasting peace.

AI is reshaping workplaces, particularly in retail. Researchers explored how AI service quality impacts retail employees’ innovation, job fit, and satisfaction. Findings show when employees perceive AI as reliable and empathetic, they are more likely to engage in innovative behavior. AI’s adaptability also plays a crucial role in enhancing service quality. While reliability strongly supports innovation, transparency and responsiveness had less influence than expected. Empathy in AI systems was found to have a significant positive effect on employee innovation, creating a more engaging work environment. The study underscores AI’s potential to drive service innovation in retail.

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicineat Texas Tech University Health Sciences Center (TTUHSC) and director of the University Medical Center (UMC) Cancer Center, shared groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study. The findings underscore the critical role of tumor size reduction in improving survival outcomes for patients with advanced renal cell carcinoma (aRCC).

New research has emerged on the development of a novel membrane distillation system and an adsorbent (a substance that can trap chemicals on its surface) for the removal of hazardous perfluoroalkyl and polyfluoroalkyl substances (PFAS). Scientists from Institute of Science Tokyo, Japan, utilized carbon-based materials to successfully remove PFAS from water. This innovative approach could contribute to sustainable purification technologies in the future.